Clinical Trials Directory

Trials / Completed

CompletedNCT00264511

Hyperbaric Oxygen in Lower Leg Trauma

Does Hyperbaric Oxygen Reduce Complications and Improve Outcomes After Open Tibial Fractures With Severe Soft Tissue Injury? An International Multi-centre Randomized Controlled Trial.

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Bayside Health · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study hypothesis :Hyperbaric Oxygen may prevent complications and improve outcomes in severe lower limb trauma. We propose to investigate this hypothesis by conducting an International multi centre randomised control trial of standard trauma/orthopaedic care with or without a concurrent course of hyperbaric oxygen treatments.

Detailed description

A randomised controlled trial was undertaken on using hyperbaric oxygen in addition to standard orthopaedic trauma care in severe lower leg injury, defined as an open tibial fracture with severe soft tissue injury. The control arm subjects received standard hospital trauma care whilst the intervention group received standard trauma care with the addition of hyperbaric oxygen therapy with the aim of providing 12 HBOT sessions over the first 9 days of hospital care. The primary outcome measure was the incidence of wound necrosis AND/OR wound infection as assessed at Day 14, with secondary outcomes of wound closure, wound complications, infections and delayed bone union at 12 months plus quality of life and functional questionnaire outcomes at 12 months and 2 years. The detailed study protocol was published in in June 2015 and the results were published in September 2022. Both publications are Open Access (See References section for publication details)

Conditions

Interventions

TypeNameDescription
OTHERHyperbaric Oxygen TreatmentSubjects in the HBO treatment group will receive a course of hyperbaric oxygen therapy (HBO) in addition to normal trauma and general care. A total of 12 HBO sessions will be delivered over approximately 8 days. HBO treatment will be provided at 2.4 atmospheres absolute (ATA) pressure for approximately 90 minutes of oxygen therapy. Treatments should be twice daily for the first three days. Minor variability will be allowed with respect to timing and profile of each session.

Timeline

Start date
2007-02-13
Primary completion
2014-08-18
Completion
2016-03-23
First posted
2005-12-13
Last updated
2023-09-05

Locations

10 sites across 9 countries: United States, Australia, Austria, Chile, Czechia, India, Italy, Portugal, Sweden

Source: ClinicalTrials.gov record NCT00264511. Inclusion in this directory is not an endorsement.